Skip to content
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
×
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
/
Specialty
/
Cardiology
/ Emerging Strategies in the Management of Dyslipidemia in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia: PCSK9 Inhibitors (Evolocumab and Alirocumab)
Emerging Strategies in the Management of Dyslipidemia in Patients with Atherosclerotic Cardiovascular Disease and Familial Hypercholesterolemia: PCSK9 Inhibitors (Evolocumab and Alirocumab)
Complimentary
Categories:
Activity Type
,
ANCC
,
Cardiology
,
CME
,
Credit Type
,
Endocrinology
,
Family Medicine
,
Nurse
,
Nurse Practitioner
,
Online Activity
,
Physician
,
Physician Assistant
,
Profession
Related products
Novel Therapies for Chronic Rhinosinusitis with Nasal Polyps
Read more
Advances in Biological Therapies for Atopic Dermatitis in Adults and Children
Read more
New Paradigms in the Treatment and Management of Neovascular Age-related Macular Degeneration (nAMD)
Read more
Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes
Read more
Scroll To Top